This report presents forecasts of global and regional health burden due to AMR using historical estimates from the Global Research on Antimicrobial Resistance (GRAM) Project. This analysis also quantifies the health gains possible from key interventions, such as developing new antimicrobials that targets resistant bacteria, or improved healthcare for treating severe infections and better access to existing antimicrobials.